Wang Lai has filed 35 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 55029 shares of BeOne Medicines Ltd. ($ONC) on March 06, 2026.
Activity breakdown: 0 open-market purchases and 27 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | BeOne Medicines Ltd. | $ONC | Wang Lai | President, Global Head of R&D | A | Ordinary Shares | 55029 | $0.00 | 2,221,024.0000 | 1,488,750,354 | 2.54% | 0.00% |
| March 6, 2026 | BeOne Medicines Ltd. | $ONC | Wang Lai | President, Global Head of R&D | A | Ordinary Shares | 112606 | $0.00 | 2,165,995.0000 | 1,488,750,354 | 5.48% | 0.01% |
| Dec. 31, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | President, Global Head of R&D | A | Ordinary Shares | 427895 | $0.00 | 2,053,389.0000 | 1,488,750,354 | 26.32% | 0.03% |
| Sept. 9, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 5000 | $350.06 | 0.0000 | 1,368,746,793 | 100.00% | 0.00% |
| July 29, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 2949 | $302.00 | 1,351.0000 | 1,368,746,793 | 68.58% | 0.00% |
| July 29, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 292 | $302.92 | 1,059.0000 | 1,368,746,793 | 21.61% | 0.00% |
| July 29, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 800 | $304.16 | 259.0000 | 1,368,746,793 | 75.54% | 0.00% |
| July 30, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 259 | $305.00 | 0.0000 | 1,368,746,793 | 100.00% | 0.00% |
| July 18, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 700 | $300.00 | 0.0000 | 1,368,746,793 | 100.00% | 0.00% |
| June 23, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 1028 | $260.00 | 0.0000 | 1,368,746,793 | 100.00% | 0.00% |
| June 16, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 1177 | $266.40 | 470.0000 | 1,368,746,793 | 71.46% | 0.00% |
| June 17, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 470 | $251.37 | 0.0000 | 1,368,746,793 | 100.00% | 0.00% |
| June 10, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | A | Ordinary Shares | 86359 | $0.00 | 1,790,269.0000 | 1,368,746,793 | 5.07% | 0.01% |
| June 10, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | A | Share Option (Right to Buy) | 162565 | $0.00 | 162,565.0000 | 1,368,746,793 | 9999.99% | 0.01% |
| June 6, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 300 | $255.30 | 0.0000 | 1,368,746,793 | 100.00% | 0.00% |
| June 6, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 600 | $250.71 | 802.0000 | 1,368,746,793 | 42.80% | 0.00% |
| June 6, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 202 | $251.89 | 600.0000 | 1,368,746,793 | 25.19% | 0.00% |
| June 6, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 300 | $253.19 | 300.0000 | 1,368,746,793 | 50.00% | 0.00% |
| March 5, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | A | Ordinary Shares | 69251 | $0.00 | 1,722,136.0000 | 1,368,746,793 | 4.19% | 0.01% |
| Feb. 21, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 1782 | $258.73 | 400.0000 | 1,368,746,793 | 81.67% | 0.00% |
| Feb. 21, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 400 | $260.17 | 0.0000 | 1,368,746,793 | 100.00% | 0.00% |
| Feb. 21, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 437 | $258.18 | 2,182.0000 | 1,368,746,793 | 16.69% | 0.00% |
| Feb. 21, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 479 | $256.70 | 2,619.0000 | 1,368,746,793 | 15.46% | 0.00% |
| Feb. 21, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 575 | $255.86 | 3,098.0000 | 1,368,746,793 | 15.65% | 0.00% |
| Feb. 21, 2025 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 1327 | $254.82 | 3,673.0000 | 1,368,746,793 | 26.54% | 0.00% |
| Sept. 27, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 5000 | $220.35 | 0.0000 | 1,357,034,547 | 100.00% | 0.00% |
| June 24, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 2 | $161.10 | 0.0000 | 1,357,034,547 | 100.00% | 0.00% |
| June 24, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 1062 | $159.80 | 2.0000 | 1,357,034,547 | 99.81% | 0.00% |
| June 18, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 841 | $153.75 | 0.0000 | 1,357,034,547 | 100.00% | 0.00% |
| June 17, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 478 | $159.00 | 1,626.0000 | 1,357,034,547 | 22.72% | 0.00% |
| June 17, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 485 | $159.42 | 1,141.0000 | 1,357,034,547 | 29.83% | 0.00% |
| June 17, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 300 | $159.90 | 841.0000 | 1,357,034,547 | 26.29% | 0.00% |
| June 17, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | S | American Depositary Shares | 237 | $158.50 | 2,104.0000 | 1,357,034,547 | 10.12% | 0.00% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | A | Ordinary Shares | 168935 | $0.00 | 1,827,150.0000 | 1,357,034,547 | 10.19% | 0.01% |
| June 5, 2024 | BeOne Medicines Ltd. | $ONC | Wang Lai | Global Head of R&D | A | Share Option (Right to Buy) | 318253 | $0.00 | 318,253.0000 | 1,357,034,547 | 9999.99% | 0.02% |